Ameriprise’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $349K | Sell |
99,341
-20,628
| -17% | -$84.5K | ﹤0.01% | 3712 |
|
|
2025
Q4 | $404K | Hold |
119,969
| – | – | ﹤0.01% | 3704 |
|
|
2025
Q3 | $157K | Buy |
119,969
+71,842
| +149% | +$74.4K | ﹤0.01% | 3931 |
|
|
2025
Q2 | $34.5K | Sell |
48,127
-1,494
| -3% | -$1.17K | ﹤0.01% | 3928 |
|
|
2025
Q1 | $72.9K | Sell |
49,621
-515,997
| -91% | -$1.23M | ﹤0.01% | 3914 |
|
|
2024
Q4 | $2.51M | Sell |
565,618
-32,584
| -5% | -$132K | ﹤0.01% | 2796 |
|
|
2024
Q3 | $2.46M | Sell |
598,202
-40,125
| -6% | -$216K | ﹤0.01% | 2804 |
|
|
2024
Q2 | $4.16M | Buy |
638,327
+25,920
| +4% | +$183K | ﹤0.01% | 2444 |
|
|
2024
Q1 | $5.33M | Sell |
612,407
-174,641
| -22% | -$2.12M | ﹤0.01% | 2319 |
|
|
2023
Q4 | $9M | Buy |
787,048
+74,057
| +10% | +$733K | ﹤0.01% | 1876 |
|
|
2023
Q3 | $6.87M | Buy |
712,991
+118,367
| +20% | +$1.16M | ﹤0.01% | 2031 |
|
|
2023
Q2 | $6.33M | Sell |
594,624
-36,643
| -6% | -$394K | ﹤0.01% | 2163 |
|
|
2023
Q1 | $6.64M | Buy |
631,267
+24,127
| +4% | +$270K | ﹤0.01% | 2108 |
|
|
2022
Q4 | $7.52M | Buy |
607,140
+31,574
| +5% | +$358K | ﹤0.01% | 1991 |
|
|
2022
Q3 | $5.96M | Sell |
575,566
-37,455
| -6% | -$425K | ﹤0.01% | 2082 |
|
|
2022
Q2 | $7.07M | Buy |
613,021
+583,941
| +2,008% | +$6.88M | ﹤0.01% | 2028 |
|
|
2022
Q1 | $365K | Sell |
29,080
-7,675
| -21% | -$88K | ﹤0.01% | 3581 |
|
|
2021
Q4 | $429K | Sell |
36,755
-28,078
| -43% | -$344K | ﹤0.01% | 3569 |
|
|
2021
Q3 | $846K | Buy |
64,833
+29,148
| +82% | +$377K | ﹤0.01% | 3230 |
|
|
2021
Q2 | $459K | Sell |
35,685
-1,469
| -4% | -$16.8K | ﹤0.01% | 3484 |
|
|
2021
Q1 | $416K | Buy |
+37,154
| New | +$392K | ﹤0.01% | 3473 |
|
|
2020
Q2 | – | Sell |
-59,909
| Closed | -$605K | – | 3707 |
|
|
2020
Q1 | $605K | Buy |
+59,909
| New | +$704K | ﹤0.01% | 3046 |
|
|
2018
Q4 | – | Sell |
-12,822
| Closed | -$199K | – | 3707 |
|
|
2018
Q3 | $199K | Buy |
+12,822
| New | +$203K | ﹤0.01% | 3549 |
|
|
2018
Q1 | – | Sell |
-89,671
| Closed | -$1.13M | – | 3654 |
|
|
2017
Q4 | $1.13M | Sell |
89,671
-1,388
| -2% | -$18.1K | ﹤0.01% | 2922 |
|
|
2017
Q3 | $1.2M | Sell |
91,059
-2,000
| -2% | -$27.5K | ﹤0.01% | 2874 |
|
|
2017
Q2 | $1.47M | Buy |
+93,059
| New | +$1.35M | ﹤0.01% | 2754 |
|
|
2014
Q4 | – | Sell |
-3,833
| Closed | -$42K | – | 4054 |
|
|
2014
Q3 | $42K | Buy |
3,833
+442
| +13% | +$5.06K | ﹤0.01% | 4092 |
|
|
2014
Q2 | $44K | Sell |
3,391
-2,000
| -37% | -$21.7K | ﹤0.01% | 3955 |
|
|
2014
Q1 | $56K | Buy |
5,391
+96
| +2% | +$1.08K | ﹤0.01% | 3745 |
|
|
2013
Q4 | $52K | Sell |
5,295
-3,523
| -40% | -$31.6K | ﹤0.01% | 3645 |
|
|
2013
Q3 | $88K | Sell |
8,818
-633
| -7% | -$6.21K | ﹤0.01% | 3521 |
|
|
2013
Q2 | $79K | Buy |
+9,451
| New | +$115K | ﹤0.01% | 3480 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Ameriprise's IRWD Position: Q1 2026 in Review
Ameriprise reduced its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q1 2026, selling an estimated $84.5K and leaving 99,341 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #3712.
Ameriprise first reported a position in IRWD in Q2 2013 and has held it in 32 quarters since. The position peaked at $9M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Ameriprise held 99,341 shares of Ironwood Pharmaceuticals worth $349K as of Q1 2026.
- Ameriprise sold 20,628 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $84.5K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3712 holding.
- Ameriprise first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
- Ameriprise's Ironwood Pharmaceuticals position peaked at $9M in Q4 2023.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.